Hypertrophic cardiomyopathy is one of the most prominent cardiovascular diseases, with almost 1 in 500 people suffering from it. It is of great importance for this disease to be detected in a timely manner, so that patients can be provided with an adequate therapy. This is also important for monitoring the future development of the disease so that those patients under a high risk of sudden cardiac death can be provided with lifesaving implantable cardioverter-defibrillators. Regression models were created for the purpose of this paper using the random forest regression algorithm to monitor the future states of patients based on their previously known parameters. Regression models were built by maximizing R2 score for important patient parameters. The training of classification models was done using the random forest and extreme gradient boosted trees algorithms for the purposes of risk prediction. The classification models achieved 96% and 99% F1 score over the high-risk class respectively and 99% prediction accuracy overall.
Ammirati E, Contri R, Coppini R, Cecchi F, Frigerio M, Olivotto I. Pharmacological treatment of hypertrophic cardiomyopathy: Current practice and novel perspectives. *European Journal of Heart Failure*. 2016;18(9):1106–18.
2.
Augusto JB, Davies RH, Bhuva AN, Knott KD, Seraphim A, Alfarih M, et al. Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: A comparison with human test-retest performance. *The Lancet Digital Health*. 2021;3(1):20–8.
3.
Aurore L, Rina A, Ana M, Masliza M, Elizabeth O, Pablo L, et al. Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers. *Frontiers in Physiology*. 2018;9.
4.
Boulesteix AL, Janitza S, Kruppa J, König IR. Overview of random forest methodology and practical guidance with emphasis on computational biology and bioinformatics. *Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery*. 2012;2(6):483–507.
Christiaans I, Engelen K v, Langen IM, Birnie E, Bonsel GJ, Elliott PM, et al. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Systematic review of clinical risk markers. *EP Europace*. 2010;12(3):313–21.
7.
Cardiology C. *Genetic testing for hypertrophic cardiomyopathy*.
8.
Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary. 2011.
Jordà P, García-Álvarez A. Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults. *Global Cardiology Science and Practice*. 2018;
11.
Katritsis DG, Zareba W, Camm AJ. Nonsustained ventricular tachycardia. *Journal of the American College of Cardiology*. 2012;60(20).
12.
Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression. *Nature Reviews Cardiology*. 2008;5.
13.
Kochav SM, Raita Y, Fifer MA, Takayama H, Ginns J, Maurer MS, et al. Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning. *International Journal of Cardiology*. 2021;327:117–24.
14.
Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. *Circulation Research*. 2017;121:749–70.
15.
O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD. *European Heart Journal*. 2014;35(30):2010–20.
16.
Smole T, Žunkovič B, Pičulin M, Kokalj E, Robnik-Šikonja M, Kukar M, et al. A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy. *Computers in Biology and Medicine*. 2021;135.
17.
Tse G, Zhou J, Woo SW, Ko CH, Lai RW, Liu T, et al. Multi-modality machine learning approach for risk stratification in heart failure with left ventricular ejection fraction ≤ 45%. *ESC Heart Failure*. 2020;7(6):3716–25.
18.
Wasan P, Uttamchandani M, Moochhala S, Yap V, Yap P. Application of statistics and machine learning for risk stratification of heritable cardiac arrhythmias. *Expert Systems with Applications*. 2013;40(7):2476–86.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
